Therapy of solid tumors using probiotic Symbioflor-2 - restraints and potential-Reference-Cited by-同舟云学术

Therapy of solid tumors using probiotic Symbioflor-2 - restraints and potential

Published:2016-03-10 Issue:16 Volume:7 Page:22605-22622
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Kocijancic Dino¹,Felgner Sebastian¹,Frahm Michael¹,Komoll Ronja-Melinda¹,Iljazovic Aida¹,Pawar Vinay¹,Rohde Manfred²,Heise Ulrike³,Zimmermann Kurt⁴,Gunzer Florian⁵,Hammer Juliane¹,Crull Katja¹,Leschner Sara¹,Weiss Siegfried¹⁶

Affiliation:

1. Department of Molecular Immunology, Helmholtz Centre for Infection Research, Braunschweig, Germany

2. Central Facility for Microscopy, Helmholtz Centre for Infection Research, Braunschweig, Germany

3. Mouse-Pathology Service Unit, Helmholtz Centre for Infection Research, Braunschweig, Germany

4. Symbio Gruppe GmbH & Co KG, Herborn, Germany

5. Institute of Medical Microbiology and Hygiene, Dresden University of Technology, Dresden, Germany

6. Institute of Immunology, Medical School Hannover, Hannover, Germany

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 36 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Genome Engineering as a Therapeutic Approach in Cancer Therapy: A Comprehensive Review;Advanced Genetics;2024-02-05

2. Bacteria-Based Nanoprobes for Cancer Therapy;International Journal of Nanomedicine;2024-01

3. Advances in the Application of Bacteria in Tumor Therapy;Hans Journal of Biomedicine;2024

4. Engineered E. coli Nissle 1917 for delivery of bioactive IL-2 for cancer immunotherapy;Scientific Reports;2023-08-02

5. A tale of two bacteria – Bacteroides fragilis, Escherichia coli, and colorectal cancer;Frontiers in Bacteriology;2023-07-26